Spurr Robert 4

4 · Bausch Health Companies Inc. · Filed May 12, 2022

Form 4

Period: 2022-05-10

President, Salix

Transactions

Exercise/Conversion
Common Shares, No Par Value
2022-05-10+8,643→ 99,149 total
Exercise/Conversion
Common Shares, No Par Value
2022-05-10+13,592→ 112,741 total
Exercise/Conversion
Restricted Share Units
2022-05-10$9.40/sh−8,643$81,244→ 0 total
Exp: 2022-05-10→ Common Shares, No Par Value (0 underlying)
Award
Restricted Share Units
2022-05-10+8,643→ 0 total
Exp: 2022-05-10→ Common Shares, No Par Value (8,643 underlying)
Exercise/Conversion
Restricted Share Units
2022-05-10$9.40/sh−13,592$127,765→ 0 total
Exp: 2022-05-10→ Common Shares, No Par Value (0 underlying)
Award
Restricted Share Units
2022-05-10+13,592→ 0 total
Exp: 2022-05-10→ Common Shares, No Par Value (13,592 underlying)

Footnotes (3)

[F1]Reflects an award of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service.
[F2]Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service.
[F3]Each PSU converts into common shares, no par value, of the Issuer on a one-for-one basis.

Documents

2 files